XML 112 R84.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock Plans and Management Compensation (Details 3) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Percentage of Premium Paid Out in Deferred Company Common Stock 20.00%    
Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-Based Compensation Expense $ 0.0 $ 2.1 $ 3.6
Share-Based Compensation Expense, Tax Benefit 0.0 0.5 0.9
Fair Value of Shares Vested During the Period $ 7.5 $ 16.2 $ 14.6
Share-Based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Outstanding at January 1 217,000    
Awarded Grants in Period 174,000    
Forfeited (15,000)    
Vested (117,000)    
Outstanding at December 31 259,000 217,000  
Weighted Average Grant Date Fair Value $ 83.09 $ 90.09  
Awarded - Weighted Average Grant Date Fair Value 83.20    
Forfeited - Weighted Average Grant Date Fair Value 50.74    
Vested - Weighted Average Grant Date Fair Value $ 100.42    
Unrecognized Compensation Cost $ 3.4    
Unrecognized Compensation Cost, Period for Recognition 1 year 6 months    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 2 years 10 months 24 days 2 years 10 months 24 days 2 years 10 months 24 days
Non-Vested Stock Awards [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-Based Compensation Expense $ 23.3 $ 20.4 $ 18.2
Share-Based Compensation Expense, Tax Benefit 5.7 5.0 4.5
Fair Value of Shares Vested During the Period $ 10.9 $ 24.5 $ 16.7
Share-Based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Outstanding at January 1 577,000    
Awarded Grants in Period 350,000    
Forfeited (37,000)    
Vested (168,000)    
Outstanding at December 31 722,000 577,000  
Weighted Average Grant Date Fair Value $ 88.97 $ 90.72  
Awarded - Weighted Average Grant Date Fair Value 87.16 $ 88.00 $ 93.62
Forfeited - Weighted Average Grant Date Fair Value 89.19    
Vested - Weighted Average Grant Date Fair Value $ 91.11    
Unrecognized Compensation Cost $ 18.8    
Age of Grantee   62 years  
Unrecognized Compensation Cost, Period for Recognition 1 year 2 months 12 days    
Awards Vesting Period (in years) 3 years    
Stock Options and SAR's [Member]      
Share-Based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Period for Stock Options and SARs to be Exercisable (in years) 10 years    
Awards Vesting Period (in years) 4 years    
Outstanding on December 31 1 month 6 days    
Exercisable and Vested on December 31 1 month 6 days    
Vested and Expected to Vest on December 31 1 month 6 days    
Stock Options and SAR's [Member] | $23.79 [Member]      
Share-Based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Outstanding Options, Weighted Average Remaining Years of Contractual Life (in years) 1 year 1 month 6 days    
Stock Options and SAR's [Member] | Greater Than $14.68 [Member]      
Share-Based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Outstanding Options, Weighted Average Remaining Years of Contractual Life (in years) 1 month 6 days    
Stock Options and SAR's [Member] | $5.87 to $14.68 [Member]      
Share-Based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Outstanding Options, Weighted Average Remaining Years of Contractual Life (in years) 8 months 12 days    
Stock Options and SAR's [Member] | $5.86 [Member]      
Share-Based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Outstanding Options, Weighted Average Remaining Years of Contractual Life (in years) 0 years    
Share-based Payment Arrangement, Tranche Two [Member] | Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted Average Price at Grant Date (in dollars per share) $ 83.39 $ 83.97 $ 91.62
Share-Based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Awarded Grants in Period 33,610 36,170 24,320
Share-based Payment Arrangement, Tranche One [Member] | Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted Average Price at Grant Date (in dollars per share) $ 85.52 $ 88.47 $ 94.59
Risk-Free Interest Rate 4.30% 4.30% 1.70%
Dividend Yield 1.90% 1.80% 1.50%
Volatility Factor 40.50% 49.80% 54.80%